Eli Lilly LLY EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Eli Lilly in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The official record: Eli Lilly’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Eli Lilly's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Eli Lilly's EPS (diluted)?
- Eli Lilly (LLY) reported EPS (diluted) of $8.26 in Q1 2026.
- How has Eli Lilly's EPS (diluted) changed year-over-year?
- Eli Lilly's EPS (diluted) increased by 169.9% year-over-year, from $3.06 to $8.26.
- What is the long-term trend for Eli Lilly's EPS (diluted)?
- Over 4 years (2021 to 2025), Eli Lilly's EPS (diluted) has grown at a 39.1% compound annual growth rate (CAGR), from $6.13 to $22.95.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.